Astex Reviews Key Achievements in 2002
12. Dezember 2002 03:17 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Dec. 12, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today gives a review of the progress made in 2002 and comments on the outlook for the next...
Astex Expands Patent Portfolio
09. Dezember 2002 03:18 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Dec. 9, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced the issuance of a patent (U.S. Patent No. 6,484,103) covering the structure...
Astex Joins Structural Biology Partnership at the European Synchrotron Radiation Facility
11. November 2002 04:18 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Nov. 11, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has joined the new Partnership for Structural Biology (PSB)...
Astex Determines Structure of the Key Drug Metabolising Enzyme -- Human Cytochrome P450 3A4
28. Oktober 2002 04:13 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 28, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has solved the 3-dimensional crystal structure of human cytochrome...
Astex Announces Drug Discovery Collaboration with Mitsubishi Pharma Corporation
21. Oktober 2002 04:24 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 21, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery-company, today announced a drug discovery collaboration in the area of metabolic disorders with...
Astex Technology Appoints Dr. Lyn Leaper as Vice President of Intellectual Property
15. Oktober 2002 05:12 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 15, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced the appointment of Dr. Lyn Leaper as Vice President of Intellectual...
Aventis Pharmaceuticals Makes Milestone Payment to Astex
04. September 2002 03:20 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Sept. 4, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has received the first milestone payment from Aventis...
Astex Announces Structure-Based Drug Discovery Agreement with Mitsubishi Pharma Corporation
10. Juni 2002 05:40 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., June 10, 2002 (PRIMEZONE) -- Astex Technology, the U.K. structure-based drug discovery company today announced a structural biology research agreement with Mitsubishi Pharma...
Astex Announces Appointment of Vice President of Biology
14. Mai 2002 02:30 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., May 14, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography technology, today announced the...
Astex and Maybridge Announce Exclusive Lead Discovery Collaboration
07. Mai 2002 03:00 ET
|
Astex Therapeutics
CAMBRIDGE, U.K. and CORNWALL, U.K., May 7, 2002 (PRIMEZONE) -- Astex Technology, the private, structure-based drug discovery company, and Maybridge plc, a world leader in the supply of small molecule...